Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BR005-036C for acute treatment of migraine in adults
CTR20263294Phase 3Active
- Sponsor
- Xiyuan Biotech
- Start
- Aug 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of BR005-036C in migraine, sponsored by Xiyuan Biotech. Started Aug 2026; status: active.
02
Drugs
BR005-036C
03
Conditions
migraine
Beyond the preview
Go deeper on CTR20263294.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20263294.